Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)
Bangladesh · Delayed Price · Currency is BDT 148.40
-1.00 (-0.67%)
At close: Sep 24, 2026
DSE:BXPHARMA Market Cap
DSE:BXPHARMA has a market cap or net worth of 66.2 billion as of September 25, 2026. Its market cap has increased by 29.27% in one year.
Market Cap
66.20B
Enterprise Value
67.63B
Revenue
53.93B
Ranking
n/a
PE Ratio
7.65
Stock Price
148.40
ChartMarket Cap Chart
Since January 3, 2000, DSE:BXPHARMA's market cap has increased from 1.91B to 66.20B, an increase of 3,364.47%. That is a compound annual growth rate of 14.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 66.20B | 45.35% |
| Dec 30, 2025 | 45.55B | 25.12% |
| Dec 30, 2024 | 36.40B | -44.19% |
| Dec 28, 2023 | 65.22B | - |
| Dec 29, 2022 | 65.22B | -24.13% |
| Dec 30, 2021 | 85.97B | 1.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 191.47B |
| Renata | 51.49B |
| Unilever Consumer Care | 38.27B |
| Beacon Pharmaceuticals | 23.40B |
| The ACME Laboratories | 16.57B |
| Asiatic Laboratories | 12.90B |
| The IBN SINA Pharmaceutical Industry | 9.85B |
| Navana Pharmaceuticals | 6.86B |